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disease. Fewer than 20% of these patients had micrometastases
alone. Tumour size and grade influenced node status in US-suspi-
cious cases only.
Conclusion: Axillary US has a moderately high PPV and NPV in
preoperative axillary staging. US gives false negative results in
20% of cases and only a small proportion of these can be
explained by micrometastases. Taking into account tumour size
improves the predictive value of the technique.
doi:10.1016/j.ejcsup.2010.06.076
O-76 BREAST RADIOTHERAPY FOR OCCULT BREAST CANCER
WITH AXILLARY NODAL METASTASES – DOES IT REDUCE
LOCAL RECURRENCE RATE AND INCREASE OVERALL SURVIVAL?
S. Masinghe, O. Faluyi, G. Kerr, I. Kunkler. Western General
Hospital, Edinburgh, UK
Background: The optimal management of axillary lymph node
metastases from occult breast cancer (TXN1-2M0) is uncertain
and practice varies in the use of primary breast radiotherapy.
We conducted a retrospective review to examine clinical out-
comes for patients managed with or without primary breast
radiotherapy.
Materials and methods: Case records from the Clinical Oncology
database were reviewed to identify patients presenting with axil-
lary nodal metastases but no detectable primary tumour for over
the period between 1974 and 2003. Fifty three patients with TXN1-
2M0 breast cancer were identified representing 0.4% of patients
managed for breast cancer during this period. Of those tested,
59% had oestrogen receptor positive tumours. 77% received ipsi-
lateral breast radiotherapy.
Results: There was a trend towards reduced ipsilateral breast
tumour recurrence in patients who received radiotherapy (16% at
5 years, 23% at 10 years) compared to those who did not (36% at
5 years, 52% at 10 years). Similarly, the locoregional recurrence rate
at 5 years was 28% for patients who received radiotherapy com-
paredto53.7%fornonirradiatedpatients.Breast cancer specificsur-
vival was higher (p = 0.0073; log-rank test) in patients who received
ipsilateral breast radiotherapy (72%at 5 years, 66%at 10 years) com-
pared to those who did not (58% at 5 years, 15% at 10 years).
Conclusion: Primary breast radiotherapy may reduce ipsilateral
breast tumour recurrence and increase survival inpatients present-
ing with axillary lymph nodemetastases and occult breast primary
(TXN1-2M0). Larger studies are needed to validate these findings.
doi:10.1016/j.ejcsup.2010.06.077
O-77 SENTINEL LYMPH NODE BIOPSY (SLNB) BEFORE PRIMARY
CHEMOTHERAPY (PC) IN BREAST CANCER PATIENTS
J.R. Benson, G.C. Wishart, G. Ambler, E. Provenzano. Cambridge
Breast Unit, Addenbrooke’s Hospital, Cambridge, UK
SLNB prior to PC will minimize risk of a false negative result
and allow more accurate initial staging which can guide treat-
ment decisions for adjuvant radiotherapy and axillary surgery.
A retrospective analysis was undertaken to examine upfront
SLNB amongst 46 patients with clinically node negative, non-
inflammatory invasive breast cancers measuring between 2 and
5 cm on initial imaging (irrespective of modality). Axillary ultra-
sound was performed in most patients (43/46), 10 of whom had
a negative core biopsy. Mean tumour diameter was 28.5 cm and
two patients had axillary lymph node dissection (ALND)
prompted by subsequent MRI size estimate (>5 cm). Dual localiza-
tion methods were employed and micrometastatic foci identified
on H&E sections; immunohistochemistry was not routinely
performed.
The sentinel node was identified in all patients with a mean of
2.7 nodes per patient (range 1–6). A total of 13 patients had posi-
tive nodes (28%) with 10 having involvement of a single node
(eight macrometastases; two micrometastases) and three
patients with two separate nodes, both containing a macrometas-
tasis (two patients) or each a macro- and micrometastasis (one
patient). The mean number of nodes removed on completion
ALND was 10.9 (range 7–32). Only one patient had tumour (micro-
metastasis) within a non-sentinel node (NSLN) and one other
patient had evidence of fibrosis suggesting tumour response to
PC.
A group of patients can be selected for SLNB before PC who
have a relatively low axillary tumour burden at presentation.
Potential downstaging with PC may result in a low incidence of
NSLN involvement with viable tumour.
doi:10.1016/j.ejcsup.2010.06.078
O-78 COMPARISON BETWEEN ENDOSCOPE-ASSISTED PARTIAL
MASTECTOMY WITH FILLING OF DEAD SPACE USING ABSORB-
ABLE MESH AND CONVENTIONAL CONSERVATIVE METHOD ON
COSMETIC OUTCOME IN PATIENTS WITH STAGES 1 AND 2
BREAST CANCER
Nobuyuki Takemoto a, Ai Koyanagi b. aDepartment of Breast and
Endocrine Surgery, Japan Medical Alliance Higashi Saitama General
Hospital, Japan. bDepartment of Global Health Policy, University of
Tokyo, Japan
Background and aims: Breast conservative therapy is currently
the mainstream of breast cancer treatment. There is increasing
interest in methods to further improve postoperative cosmesis
such as endoscopic surgery which was introduced in 1994 as an
alternative to Conventional Conservative Method (CCM). How-
ever, data on whether endoscopic surgery confers any additional
benefit to CCM in terms of cosmesis is lacking. We compared cos-
metic outcome between CCM and Endoscope-assisted Partial
Table 1
Variable PPV (%) NPV (%)
US suspicious vs. US negative – all cases 59 81
T1 vs. T2 – all cases 47 74
T2 cases – US suspicious vs. US negative 75 75
T1 cases – US suspicious vs. US negative 51 86
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Mastectomy (EAPM) with filling of the dead space using absorb-
able meshes (polyglactin and cellulose).
Patients and methods: A total of 111 patients with stages I and II
breast cancer who underwent CCM (n = 51) or EAPM (n = 60) fol-
lowed by definitive radiation therapy between 1997 and 2007 were
retrospectively reviewed. Postoperative cosmetic outcome was
compared between CCM and EAPM according to total scores
obtained based on the Al-Ghazal scorewhich grades the following
indicators on a scale of 0, 1 or 2 with larger scores corresponding
to better outcome: breast retraction assessment, nipple deviation,
atrophy, skin change and scar. Total scores of <6 and >7 were con-
sidered unsatisfactory and satisfactory respectively. We also per-
formed individual analyses by the five indicators where we
considered score 2 as satisfactory, and 0 and 1 as unsatisfactory.
Results:APM was associated with a significantly higher rate of
satisfactory results compared to CCM (71.7% versus 52.9%;
p = 0.042), particularly for atrophy (55.0% versus 29.4%; p = 0.007)
and scar (55.0% versus 31.4%; p = 0.012).
Conclusion: EAPM is superior to CCM for postoperative cos-
metic outcome, in particular, with respect to atrophy and scar.
doi:10.1016/j.ejcsup.2010.06.079
O-79 EFFECT OF LYMPHOVASCULAR INVASION (LVI) ON LOCAL
RECURRENCE AFTER WIDE LOCAL EXCISION (WLE) AND AFTER
MASTECTOMY (MX)
R.W. Blamey, L. Cataliotti, M. Sundquist, R. Mansel, G.R. Ball, On
behalf of the ONCOPOOL Consortium
ONCOPOOL is a data set (n = 17,000) compiled from primary
operable (65 cm) breast cancers in women aged 650 in 12 Euro-
pean Breast Units, entered in 1990–1999.
Purpose of investigation: LVI has been frequently quoted as a risk
factor for Local Recurrence.
Method: LVI was regularly measured by H & E staining in four
units (n = 4193). 20% were LVI+.
Results:
 1997 underwent Wide Local Excision (WLE) + postoperative
RT.% LR rates at 10 years were: LVI– (n = 1610) 8 ± 1 and
LVI+ (n = 387) 14 ± 2.Cox Analysis entering also the Notting-
ham Prognostic Index (NPI) showed no individual signifi-
cance to LVI; the small overall difference was because
more LVI+ cases lay in the poorer NPI groups.
 2196 underwent Mastectomy (Mx).
LVI– LVI+
n % LR & 10 years n % LR @ 10 years
1458 8 ± 1 738 11 ± 1
Cox analysis entering LVI and NPI showed no significance to
LVI.
Conclusions:
 LR after WLE arises from residual primary tumour which LVI
cannot influence.
 LR in skin is metastatic, probably through lymphatic chan-
nels but LR of this type is rare after RT.
doi:10.1016/j.ejcsup.2010.06.080
O-80 LOBULAR NEOPLASIA AND CONSERVATIVE SURGICAL
MANAGEMENT
B.S. Mothe, Tani Fasih, David Browell, Kevin Clark. Queen Elizabeth
Hospital, Gateshead, UK
Introduction: Lobular neoplasia (LN) is a well recognised breast
condition which describes spectrum of lesions including atypical
lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS).
The significance of LN is poorly understood and a diagnosis of
ALH/LCIS in the present clinical practice is often seen as a ‘risk
indicator’ for future carcinoma rather than a true precursor. Var-
ious treatment options have been recorded in literature but the
management of this condition has been much debated and at
times been controversial. In this paper we present the results of
our study of 25 cases of LN from 1996 to 2008.
Method and materials: Retrospective review of patients with his-
tology proven LN was undertaken. All patients had triple assess-
ment including standard core needle biopsy (CNB) for lesions
identified on ultrasound scan (USS) and 2-view mammography.
Biopsies reported as ALH/LCIS and staging of B3 underwent diag-
nostic guide wire excision biopsy (DGWB).
Results: A total of 25 LN caseswere identified and age range var-
ied from 40 years to 75 years. All patients who had excision biopsy
were followed up for at least 5 years annually and subsequently
they were returned to routine breast screening programme.
Median age at diagnosis was 56 years and mean follow-up was
5.08 years for this set of patients (range 1–12 years). Results
showed 23 patients were pure LCIS (92%), 2 (8%) were found to
have atypical ductal hyperplasia (ADH) focus along with LCIS in
the excision biopsy (DGWB). Bilateral LCIS disease was noted in
4 (16%) of 25.4 (16%) cases went on to develop invasive cancer.
The mean time interval from the time of diagnosis to developing
cancer was 1.75 years. 3 (12%) out of the four patients with LCIS
developed cancer within the same breast and 1 patient (4%) had
developed papillary cancer in the contralateral breast on long
term follow-up. It is interesting to note that out of the invasive
cancer group of 3 patients 2 (66.6%) had bilateral LCIS condition.
All invasive cancer patients underwent mastectomy on side of
disease and 2 patients had prophylactic mastectomy by choice.
Conclusion: This study agreeswith the available evidence in liter-
ature about LCIS being a precursor of invasive cancer and the inci-
dence seems to be around 12% in our study. Guide wire excision
biopsy for CNB proven LCIS patients followed by annual review
and surveillance mammography seems to work well in detecting
recurrences andhence it is recommended for this groupofpatients.
We conclude that prophylactic mastectomy for all patients
with LN is not necessary and close observation alone seems an
appropriate treatment option.
doi:10.1016/j.ejcsup.2010.06.081
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